(R)-1-(3-(Trifluoromethoxy)phenyl)ethanamine hydrochloride, 95.0%, 250mg

2-Amino-5-tert-butyl-1,3,4-thiadiazole, 97.0%, 25g

2-[1-(3-fluorophenyl)cyclopropyl]acetic acid, >95%, 1g

5-BROMO-2-METHYLISOQUINOLIN-1(2H)-ONE, 95.0%, 1g

4-(Piperidin-1-ylsulfonyl)-2-trifluoromethylphenylboronic acid, 97%, 250mg

3-Bromo-5-(trifluoromethoxy)benzaldehyde, 95.0%, 25g

Tri-Potassium Citrate Monohydrate, min. 99%, Ph.Eur., USP, 1 kg, plastic packaging.

4-(N-Maleimidomethyl)cyclohexane-1-carboxylic Acid>98.0%(GC)5g

(1R,2R)-2-(4-Bromophenyl)cyclopropane-1-carboxylic acid, 98+%, 1g

(3-((1-(tert-Butoxycarbonyl)piperidin-4-yl)carbamoyl)phenyl)boronic acid, 95+%, 250mg

N-(4-Nitrophenyl)-4-(3-pyridyl)-2-pyrimidineamine, 98%, 250mg

2-Chloro-6-methylbenzaldehyde, 98.0%, 10g

7-BOC-7-AZASPIRO[3.5]NONANE-2-CARBOXYLIC ACID, 97.0%, 1g